US3891573A - Aqueous cholesterol standard solution - Google Patents

Aqueous cholesterol standard solution Download PDF

Info

Publication number
US3891573A
US3891573A US465640A US46564074A US3891573A US 3891573 A US3891573 A US 3891573A US 465640 A US465640 A US 465640A US 46564074 A US46564074 A US 46564074A US 3891573 A US3891573 A US 3891573A
Authority
US
United States
Prior art keywords
standard solution
component
solution
cholesterol
percent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US465640A
Inventor
Emil Stary
Peter Roeschlau
Erich Bernt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of US3891573A publication Critical patent/US3891573A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104165—Lipid, cholesterol, or triglyceride standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Definitions

  • the present invention relates to a cholesterol standard solution, more specifically, an aqueous solution of cholesterol with a definite and stable content of cholesterol.
  • cholesterol solutions with a definite, known content of cholesterol as standard.
  • cholesterol solutions are used with a definite cholesterol content which are called cholesterol standards.
  • the cholesterol is dissolved in glacial acetic acid, chloroform, absolute alcohol or the like.
  • the anhydrous standard solution so obtained gives, in the case of a cholesterol determination with the Liebermann- Burchardt color reagent, a color intensity which is different from that obtained with serum and can result in false cholesterol values in the serum (see L. Vass, Nurse. med. Wschr., 102 914/1972).
  • aqueous cholesterol standard solution which contain hydroxypolyethoxydodecane as solubilizing agent, in turn suffer from a serious disadvantage insofar as the cholesterol content thereof changes rapidly and decreases noticeably even in the course of a few days.
  • a cholesterol standard solution especially important that the cholesterol content thereof remains absolutely constant, it was hitherto necessary freshly to prepare the aqueous cholesterol standard solution before use, which was a considerable disadvantage and, in addition, rendered questionable the dependability of the cholesterol determination.
  • the present invention obviates or mitigates these disadvantages and provides a stable, aqueous cholesterol standard solution.
  • the present invention provides an aqueous cholesterol standard solution, comprising, in aqueous solution, a known amount of cholesterol, together with 1 to 20 volume percent of a primary or secondary aliphatic alcohol containing up to 4 carbon atoms (for example, ethanol, isopropanol or n-butanol); 5 to 20 volume percent of hydroxy-polyethoxydodecane or 40 to 60 volume percent diethyleneglycol monobutyl ether; and 0.5 to 5 weight percent sodium chloride and/or 0.01 to 0.5 weight percent alkyl dimethyl-benzyl ammonium chloride with 8 to 18 carbon atoms in the alkyl radicals.
  • a primary or secondary aliphatic alcohol containing up to 4 carbon atoms
  • hydroxy-polyethoxydodecane or 40 to 60 volume percent diethyleneglycol monobutyl ether for example, ethanol, isopropanol or n-butanol
  • the present invention rests on the surprising discovery that a solution of cholesterol in dilute aqueous alcohol which, as solubilizing agent, contains the given amount of hydroxy-polyethoxydodecane or diethyleneglycol monobutyl ether, and, as stabilizing agent, sodium chloride and/or alkyl dimethylbenzyl ammonium chloride, is outstandingly stable and, even when stored for a year or more under normal conditions, does not change with regard to the cholesterol content.
  • a preferred cholesterol standard solution according to the present invention contains the dilute alcohol, hydroxy-polyethoxydodecane and sodium chloride. in this preferred composition, the best results have been obtained with a content of 8 to l2 vol. percent of an alcohol, for example ethanol, isopropanol or n-butanol, and 0.8 to L0 wt. percent sodium chloride. If, instead of sodium chloride, alkyl dimethyl-benzyl ammonium chloride is used, then the preferred amount is 0.05 to 0.15 wt. percent.
  • Another preferred cholesterol standard solution according to the present invention comprises 8 to 12 vol. percent of an alcohol, 55 to 60 vol. percent diethylene glycol monobutyl ether and 0.05 to 0.15 wt. percent alkyl dimethyl-benzyl ammonium chloride.
  • Yet another preferred cholesterol standard solution according to the present invention additionally contains a small amount of tetramethylurea.
  • the amount thereof can be 0.5 to 5 vol. percent and is preferably 0.8 to 2.5 vol. percent.
  • an alkali metal azide it can be expedient, for the prevention of bacterial attack, to add an alkali metal azide.
  • the pH value must be adjusted to more than 6.5 by the addition of an appropriate buffer. It is preferred to add 0.05 to 0.2 percent and more, preferably about 0.1 percent of an alkali metal azide, for example sodium azide, in a buffer of pH 6.5 to 8, preferably of 7 to 8, for example, a triethanolamine buffer.
  • the cholesterol standard solution according to the present invention can contain up to 400 mg cholesterol in 100 ml of the solvent mixture.
  • the extraordinary storage stability of the solutions necessitates neither the exclusion of light nor the exclusion of oxygen. This is all the more surprising since, as is known, cholesterol, even in a solid state, must be stored under an inert gas and with the exclusion of light.
  • the stabilizing effect clearly depends upon the interaction of the various components of the standard solution according to the present invention since, with the individual components alone, a stabilizing effect cannot be achieved. For example, when a solution which originally contains 400 mg cholesterol in 100 ml of a mixture of 10 vol. percent hydroxy-polyethoxydodecane and vol.
  • EXAMPLE 1 40 g recrystallized cholesterol were dissolved in one liter hydroxypolyethoxydodecane by heating in a water-bath at 40C. This solution was diluted with doubly distilled water with a temperature of 40C, then ml of a 10 percent aqueous solution of alkyl dimethylbenzyl ammonium chloride and 1 liter ethanol were added thereto and, after cooling to ambient temperature, made up to precisely 10 liters with doubly distilled water.
  • EXAMPLE 2 40 g cholesterol were dissolved in 1 liter hydroxy-polyethoxydodecane and 1 liter ethanol and thereafter made up to liters with a 0.9 percent aqueous solution of sodium chloride.
  • EXAMPLE 3 40 g cholesterol were dissolved in 1 liter hydroxy-polyethoxydodecane, 1 liter n-butanol, 100ml of a 10 percent aqueous solution of alkyl dimethylbenzyl-ammonium chloride and 100 ml tetramethylurea and then made up to ID liters with doubly distilled water.
  • EXAMPLE 4 40 g cholesterol were dissolved in 6 liters diethyleneglycol monobutyl ether, 0.5 liters ethanol and 100 ml of a 10 percent aqueous solution of alkyl dimethylbenzyl-ammonium chloride were added thereto and then the mixture was made up to 10 liters with doubly distilled water.
  • Cholesterol standard solution comprising in aqueous solution a. a defined amount of cholesterol;
  • component (c) is diethyleneglycol monobutyl ether.
  • component (d) is a combination of sodium chloride and alkyl dimethyl benzyl ammonium chloride.
  • component (b) is contained in an amount of from 8 to l2 volume percent of said solution.
  • component (d) is alkyl dimethyl benzyl ammonium chloride and is contained in an amount of from 0.05 to 0.15 weight percent.
  • Standard solution as claimed in claim 7 comprising 8 to 12 volume percent of said alcohol as component (b).
  • Standard solution as claimed in claim 1 comprising 55 to 60 volume percent of diethylene glycol monobutyl ether as component (c) and 0.05 to 0. l 5 weight percent of alkyl dimethyl benzyl ammonium chloride as component (d).
  • Standard solution as claimed in claim 1 additionally containing tetramethylurea.
  • Standard solution as claimed in claim 14 wherein the content of said tetramethylurea is from 0.5 to 5 volume percent based on said standard solution.
  • Standard solution as claimed in claim 15 wherein the content of said tetramethylurea is from 0.8 to L5 volume percent based on said standard solution.
  • Standard solution as claimed in claim 1 also con- 7 taining an alkali metal azide and wherein said solution is buffered to a pH of at least 6.5.

Abstract

Highly stable cholesterol standard solution comprising a known amount of cholesterol together with 1 to 20 volume percent of a primary or secondary aliphatic alcohol containing up to 4 carbon atoms; 5 to 20 volume percent hydroxy-polyethoxydodecane or 40 to 60 volume percent diethyleneglycol monobutyl ether; and 0.5 to 5 weight percent sodium chloride and/or 0.01 to 0.5 weight percent alkyl dimethyl benzyl ammonium chloride with 8 to 18 carbon atoms in the alkyl radicals.

Description

United States Patent Stary et al.
[ June 24, 1975 AQUEOUS CHOLESTEROL STANDARD SOLUTION Inventors: Emil Stary, Hamburg; Peter Riieschlau, Tutzing, Obb; Erich Bernt, Munich, all of Germany Boehringer Mannheim Gmbll, Mannheim-Waldhof, Germany Filed: Apr. 30, 1974 Appl. No.: 465,640
Assignee:
Foreign Application Priority Data May 14. 1973 Germany 2324386 US. Cl. 252/408; 23/230 8; l95/l03.5 R Int. CL. G01n 33/16 Field of Search 23/230 B; 252/408 References Cited UNITED STATES PATENTS ll/l969 Cardinal 23/230 B 3,751,38l 8/1973 Megraw 23/230 B X 3,838,065 9/]974 Lippert et al. 252/408 FOREIGN PATENTS OR APPLICATIONS 1064,1533 4/1967 United Kingdom 23/230 B Primary Examiner-Joseph Scovronek Attorney, Agent, or Firm-Burgess, Dinklage & Sprung 5 7 1 ABSTRACT 22 Claims, No Drawings AQUEOUS CHOLESTEROL STANDARD SOLUTION The present invention relates to a cholesterol standard solution, more specifically, an aqueous solution of cholesterol with a definite and stable content of cholesterol.
A number of chemical and enzymatic processes are known or have been suggested for the quantitative determination of cholesterol in various materials, especially in biological fluids. In the case of these processes, in order to evaluate the measurement results, it is necessary to use cholesterol solutions with a definite, known content of cholesterol as standard. For this purpose, cholesterol solutions are used with a definite cholesterol content which are called cholesterol standards. In the case of the previously used standards, the cholesterol is dissolved in glacial acetic acid, chloroform, absolute alcohol or the like. However, the anhydrous standard solution so obtained gives, in the case of a cholesterol determination with the Liebermann- Burchardt color reagent, a color intensity which is different from that obtained with serum and can result in false cholesterol values in the serum (see L. Vass, Schweiz. med. Wschr., 102 914/1972).
This disadvantage can be overcome by the use of an aqueous cholesterol standard solution. However, the known aqueous cholesterol standard solutions, which contain hydroxypolyethoxydodecane as solubilizing agent, in turn suffer from a serious disadvantage insofar as the cholesterol content thereof changes rapidly and decreases noticeably even in the course of a few days. However, since it is, in the case of a cholesterol standard solution, especially important that the cholesterol content thereof remains absolutely constant, it was hitherto necessary freshly to prepare the aqueous cholesterol standard solution before use, which was a considerable disadvantage and, in addition, rendered questionable the dependability of the cholesterol determination.
The present invention obviates or mitigates these disadvantages and provides a stable, aqueous cholesterol standard solution.
The present invention provides an aqueous cholesterol standard solution, comprising, in aqueous solution, a known amount of cholesterol, together with 1 to 20 volume percent of a primary or secondary aliphatic alcohol containing up to 4 carbon atoms (for example, ethanol, isopropanol or n-butanol); 5 to 20 volume percent of hydroxy-polyethoxydodecane or 40 to 60 volume percent diethyleneglycol monobutyl ether; and 0.5 to 5 weight percent sodium chloride and/or 0.01 to 0.5 weight percent alkyl dimethyl-benzyl ammonium chloride with 8 to 18 carbon atoms in the alkyl radicals.
The present invention rests on the surprising discovery that a solution of cholesterol in dilute aqueous alcohol which, as solubilizing agent, contains the given amount of hydroxy-polyethoxydodecane or diethyleneglycol monobutyl ether, and, as stabilizing agent, sodium chloride and/or alkyl dimethylbenzyl ammonium chloride, is outstandingly stable and, even when stored for a year or more under normal conditions, does not change with regard to the cholesterol content.
A preferred cholesterol standard solution according to the present invention contains the dilute alcohol, hydroxy-polyethoxydodecane and sodium chloride. in this preferred composition, the best results have been obtained with a content of 8 to l2 vol. percent of an alcohol, for example ethanol, isopropanol or n-butanol, and 0.8 to L0 wt. percent sodium chloride. If, instead of sodium chloride, alkyl dimethyl-benzyl ammonium chloride is used, then the preferred amount is 0.05 to 0.15 wt. percent.
Another preferred cholesterol standard solution according to the present invention comprises 8 to 12 vol. percent of an alcohol, 55 to 60 vol. percent diethylene glycol monobutyl ether and 0.05 to 0.15 wt. percent alkyl dimethyl-benzyl ammonium chloride.
Yet another preferred cholesterol standard solution according to the present invention additionally contains a small amount of tetramethylurea. The amount thereof can be 0.5 to 5 vol. percent and is preferably 0.8 to 2.5 vol. percent.
Furthermore, depending upon the expected storage conditions, it can be expedient, for the prevention of bacterial attack, to add an alkali metal azide. In this case, the pH value must be adjusted to more than 6.5 by the addition of an appropriate buffer. It is preferred to add 0.05 to 0.2 percent and more, preferably about 0.1 percent of an alkali metal azide, for example sodium azide, in a buffer of pH 6.5 to 8, preferably of 7 to 8, for example, a triethanolamine buffer.
The cholesterol standard solution according to the present invention can contain up to 400 mg cholesterol in 100 ml of the solvent mixture. The extraordinary storage stability of the solutions necessitates neither the exclusion of light nor the exclusion of oxygen. This is all the more surprising since, as is known, cholesterol, even in a solid state, must be stored under an inert gas and with the exclusion of light. The stabilizing effect clearly depends upon the interaction of the various components of the standard solution according to the present invention since, with the individual components alone, a stabilizing effect cannot be achieved. For example, when a solution which originally contains 400 mg cholesterol in 100 ml of a mixture of 10 vol. percent hydroxy-polyethoxydodecane and vol. percent water, is stored for 3 weeks at 33C, only 80 percent of the original cholesterol is still found to be present. In contradistinction thereto, in the case of the standard solution according to the present invention in its various forms, even after storage for three months under the same conditions, no change of the cholesterol content can be ascertained. In the especially preferred embodiments of the present invention, complete stability was still retained after a period of storage of 2 years.
The following Examples are given for the purpose of illustrating the present invention:
EXAMPLE 1 40 g recrystallized cholesterol were dissolved in one liter hydroxypolyethoxydodecane by heating in a water-bath at 40C. This solution was diluted with doubly distilled water with a temperature of 40C, then ml of a 10 percent aqueous solution of alkyl dimethylbenzyl ammonium chloride and 1 liter ethanol were added thereto and, after cooling to ambient temperature, made up to precisely 10 liters with doubly distilled water.
EXAMPLE 2 40 g cholesterol were dissolved in 1 liter hydroxy-polyethoxydodecane and 1 liter ethanol and thereafter made up to liters with a 0.9 percent aqueous solution of sodium chloride.
EXAMPLE 3 40 g cholesterol were dissolved in 1 liter hydroxy-polyethoxydodecane, 1 liter n-butanol, 100ml of a 10 percent aqueous solution of alkyl dimethylbenzyl-ammonium chloride and 100 ml tetramethylurea and then made up to ID liters with doubly distilled water.
EXAMPLE 4 40 g cholesterol were dissolved in 6 liters diethyleneglycol monobutyl ether, 0.5 liters ethanol and 100 ml of a 10 percent aqueous solution of alkyl dimethylbenzyl-ammonium chloride were added thereto and then the mixture was made up to 10 liters with doubly distilled water.
It will be understood that the specification and examples are illustrative but not limitative of the present invention and that other embodiments within the spirit and scope of the invention will suggest themselves to those skilled in the art.
What is claimed is:
1. Cholesterol standard solution comprising in aqueous solution a. a defined amount of cholesterol;
b. l to volume percent, based on the standard solution, of a primary or secondary aliphatic alcohol of up to 4 carbon atoms;
c. 5 to 20 volume percent of hydroxy-polyethoxydodecane or 40 to 60 volume percent of diethyleneglycol monobutyl ether; and
d. at least one of i. 0.5 to 5 weight percent of sodium chloride; and ii. 0.01 to 0.5 weight percent of alkyl dimethyl benzyl ammonium chloride of from 8 to 18 carbon atoms in the alkyl moiety.
2. Standard solution as claimed in claim 1 wherein said primary or secondary aliphatic alcohol of component (b) is at least one of ethanol, isopropanol or nbutanol.
3. Standard solution as claimed in claim I wherein component (c) is hydroxy-polyethoxydodecane.
4. Standard solution as claimed in claim I wherein component (c) is diethyleneglycol monobutyl ether.
5. Standard solution as claimed in claim 1 wherein component (C!) is sodium chloride.
6. Standard solution as claimed in claim 1 wherein component (d) is alkyl dimethyl benzyl ammonium chloride.
7. Standard solution as claimed in claim 1 wherein component (d) is a combination of sodium chloride and alkyl dimethyl benzyl ammonium chloride.
8. Standard solution as claimed in claim 1 wherein component (b) is contained in an amount of from 8 to l2 volume percent of said solution.
9. Standard solution as claimed in claim 1 wherein component (c) is hydroxy-polyethoxydodecane and is contained in an amount of from 5 to 20 volume percent based on the standard solution.
10. Standard solution as claimed in claim 1 wherein component (d) is sodium chloride and is contained in an amount of from 0.8 to L0 weight percent.
11. Standard solution as claimed in claim 1 wherein component (d) is alkyl dimethyl benzyl ammonium chloride and is contained in an amount of from 0.05 to 0.15 weight percent.
12. Standard solution as claimed in claim 7 comprising 8 to 12 volume percent of said alcohol as component (b).
13. Standard solution as claimed in claim 1 comprising 55 to 60 volume percent of diethylene glycol monobutyl ether as component (c) and 0.05 to 0. l 5 weight percent of alkyl dimethyl benzyl ammonium chloride as component (d).
14. Standard solution as claimed in claim 1 additionally containing tetramethylurea.
15. Standard solution as claimed in claim 14 wherein the content of said tetramethylurea is from 0.5 to 5 volume percent based on said standard solution.
16. Standard solution as claimed in claim 15 wherein the content of said tetramethylurea is from 0.8 to L5 volume percent based on said standard solution.
17. Standard solution as claimed in claim 1 also con- 7 taining an alkali metal azide and wherein said solution is buffered to a pH of at least 6.5.
18. Standard solution as claimed in claim 17 wherein the content of said alkali metal azide is 0.05 to 0.2 percent by weight based on said standard solution.
19. Standard solution as claimed in claim 18 wherein the content of said alkali metal azide is about 0.1 weight percent.
20. Standard solution as claimed in claim 17 wherein said solution is buffered to a pH of 6.5 to 8.
21. Standard solution as claimed in claim 20 wherein said solution is buffered to a pH of 7 to 8.
22. Standard solution as claimed in claim 1 wherein the cholesterol content is up to 400 mg. per ml. of
said standard solution.

Claims (22)

1. CHOLESTEROL STANDARD SOLUTION COMPRISING IN AQUEOUS SOLUTION A. A DEFINED AMOUNT OF CHOLESTEROL; B. 1 TO 20 VOLUME PERCENT, BASED ON THE STANDARD SOLUTION, OF A PRIMARY OR SECONDARY ALIPHATIC ALCOHOL OF UP TO 4 CARBON ATOMS; C. 5 TO 20 VOLUMER PERCENT OF HYDROXY-POLYETHOXDODECANE OR 40 TO 60 VOLUME PERCENT OF DIETHYLENEGLYCOL MONOBUTYL ETHER; AND D. AT LEAST ONE OF I. 0.5 TO 5 WEIGHT PERCENT OF SODIUM CHOLRIDE; AND II. 0.001 TO 0.5 WEIGHT PERCENT OF ALKYL DIMETHYL BENZYL AMMONIUM CHLORIDE OF FROM 8 TO 18 CARBON ATOMS IN THE ALKYL MOIETY.
2. Standard solution as claimed in claim 1 wherein said primary or secondary aliphatic alcohol of component (b) is at least one of ethanol, isopropanol or n-butanol.
3. Standard solution as claimed in claim 1 wherein component (c) is hydroxy-polyethoxydodecane.
4. Standard solution as claimed in claim 1 wherein component (c) is diethyleneglycol monobutyl ether.
5. Standard solution as claimed in claim 1 wherein component (d) is sodium chloride.
6. Standard solution as claimed in claim 1 wherein component (d) is alkyl dimethyl benzyl ammonium chloride.
7. Standard solution as claimed in claim 1 wherein component (d) is a combination of sodium chloride and alkyl dimethyl benzyl ammonium chloride.
8. Standard solution as claimed in claim 1 wherein component (b) is contained in an amount of from 8 to 12 volume percent of said solution.
9. Standard solution as claimed in claim 1 wherein component (c) is hydroxy-polyethoxydodecane and is contained in an amount of from 5 to 20 volume percent based on the standard solution.
10. Standard solution as claimed in claim 1 wherein component (d) is sodium chloride and is contained in an amount of from 0.8 to 1.0 weight percent.
11. Standard solution as claimed in claim 1 wherein component (d) is alkyl dimethyl benzyl ammonium chloride and is contained in an amount of from 0.05 to 0.15 weight percent.
12. Standard solution as claimed in claim 7 comprising 8 to 12 volume percent of said alcohol as component (b).
13. Standard solution as claimed in claim 1 comprising 55 to 60 volume percent of diethylene glycol monobutyl ether as component (c) and 0.05 to 0.15 weight percent of alkyl dimethyl benzyl ammonium chloride as component (d).
14. Standard solution as claimed in claim 1 additionally containing tetramethylurea.
15. Standard solution as claimed in claim 14 wherein the content of said tetramethylurea is from 0.5 to 5 volume percent based on said standard solution.
16. Standard solution as claimed in claim 15 wherein the content of said tetramethylurea is from 0.8 to 1.5 volume percent based on said standard solution.
17. Standard solution as claimed in claim 1 also containing an alkali metal azide and wherein said solutIon is buffered to a pH of at least 6.5.
18. Standard solution as claimed in claim 17 wherein the content of said alkali metal azide is 0.05 to 0.2 percent by weight based on said standard solution.
19. Standard solution as claimed in claim 18 wherein the content of said alkali metal azide is about 0.1 weight percent.
20. Standard solution as claimed in claim 17 wherein said solution is buffered to a pH of 6.5 to 8.
21. Standard solution as claimed in claim 20 wherein said solution is buffered to a pH of 7 to 8.
22. Standard solution as claimed in claim 1 wherein the cholesterol content is up to 400 mg. per 100 ml. of said standard solution.
US465640A 1973-05-14 1974-04-30 Aqueous cholesterol standard solution Expired - Lifetime US3891573A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2324386A DE2324386C2 (en) 1973-05-14 1973-05-14 Aqueous cholestrin standard

Publications (1)

Publication Number Publication Date
US3891573A true US3891573A (en) 1975-06-24

Family

ID=5880932

Family Applications (1)

Application Number Title Priority Date Filing Date
US465640A Expired - Lifetime US3891573A (en) 1973-05-14 1974-04-30 Aqueous cholesterol standard solution

Country Status (14)

Country Link
US (1) US3891573A (en)
JP (1) JPS541197B2 (en)
AR (1) AR198369A1 (en)
AT (1) AT330368B (en)
CA (1) CA1016049A (en)
CH (1) CH592309A5 (en)
DD (1) DD110949A5 (en)
DE (1) DE2324386C2 (en)
FR (1) FR2229966B1 (en)
GB (1) GB1423113A (en)
HU (1) HU169654B (en)
IT (1) IT1010304B (en)
NL (1) NL159193B (en)
SE (1) SE393191B (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USB544476I5 (en) * 1975-01-27 1976-02-24
FR2353060A1 (en) * 1976-05-24 1977-12-23 Dorwart Jr William BLOOD SERUM STANDARD AND PREPARATION METHOD
US4141856A (en) * 1976-05-24 1979-02-27 Dorwart Jr William V Reference material for establishing anion concentrations in analytical chemistry tests
US4184921A (en) * 1976-03-25 1980-01-22 Boehringer Mannheim Gmbh Process and reagent for determining cholesterol
US4189400A (en) * 1977-08-17 1980-02-19 Bonderman Dean P Compound useful in cholesterol assay procedures
US4239649A (en) * 1979-01-25 1980-12-16 Sherwood Medical Industries Inc. Cholesterol standard
US4289649A (en) * 1978-09-11 1981-09-15 Merck Patent Gesellschaft Mit Beschrankter Haftung Aqueous lipid standard solution
US4818703A (en) * 1985-10-23 1989-04-04 Pizzolante John M Stabilized alkaline picrate reagent for jaffe creatinine determination
US4868139A (en) * 1981-06-10 1989-09-19 Boehringer Mannheim Gmbh Aqueous cholesterol standard solution and process for its preparation
US5614414A (en) * 1995-03-30 1997-03-25 Streck Laboratories, Inc. Liquid lipoprotein control
US5770451A (en) * 1995-03-30 1998-06-23 Streck Laboratories, Inc. Liquid lipoprotein control
US20110250262A1 (en) * 2008-12-24 2011-10-13 Biomedcore, Inc. Method for producing liposome and method for dissolving cholesterol

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161425A (en) * 1976-07-01 1979-07-17 Beckman Instruments, Inc. Enzymatic reagent system for total cholesterol assay using oxygen-rate method
SE452122B (en) * 1980-04-04 1987-11-16 Nippon Steel Corp PROCEDURE FOR CONTINUOUS CASTING OF STEEL PLATINES FREE OF SURFACE
FR2490228A1 (en) * 1980-09-16 1982-03-19 Biomerieux Sa PROCESS FOR THE PREPARATION OF LIPOPROTEIN SOLUTIONS FROM RESIDUES FROM DELIPIDATION OF BLOOD PLASMAS AND SERUMS AND PRODUCTS THUS OBTAINED
JPS64273U (en) * 1987-06-22 1989-01-05
JP4963126B2 (en) * 2009-06-25 2012-06-27 株式会社パロマ Spacers, fixing members and heat exchangers

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3479154A (en) * 1967-03-24 1969-11-18 Abbott Lab Method for cholesterol determination
US3751381A (en) * 1971-04-27 1973-08-07 Warner Lambert Co Dyed albumen-cohn fraction iii-lipid mixtures serum lipid assay standard
US3838065A (en) * 1971-09-10 1974-09-24 Boehringer Mannheim Gmbh Standard solution of glycerol

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3479154A (en) * 1967-03-24 1969-11-18 Abbott Lab Method for cholesterol determination
US3751381A (en) * 1971-04-27 1973-08-07 Warner Lambert Co Dyed albumen-cohn fraction iii-lipid mixtures serum lipid assay standard
US3838065A (en) * 1971-09-10 1974-09-24 Boehringer Mannheim Gmbh Standard solution of glycerol

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993585A (en) * 1975-01-27 1976-11-23 American Cyanamid Company Elevated human lipids control
USB544476I5 (en) * 1975-01-27 1976-02-24
US4184921A (en) * 1976-03-25 1980-01-22 Boehringer Mannheim Gmbh Process and reagent for determining cholesterol
FR2353060A1 (en) * 1976-05-24 1977-12-23 Dorwart Jr William BLOOD SERUM STANDARD AND PREPARATION METHOD
US4141856A (en) * 1976-05-24 1979-02-27 Dorwart Jr William V Reference material for establishing anion concentrations in analytical chemistry tests
US4189400A (en) * 1977-08-17 1980-02-19 Bonderman Dean P Compound useful in cholesterol assay procedures
US4289649A (en) * 1978-09-11 1981-09-15 Merck Patent Gesellschaft Mit Beschrankter Haftung Aqueous lipid standard solution
US4239649A (en) * 1979-01-25 1980-12-16 Sherwood Medical Industries Inc. Cholesterol standard
US4868139A (en) * 1981-06-10 1989-09-19 Boehringer Mannheim Gmbh Aqueous cholesterol standard solution and process for its preparation
US4818703A (en) * 1985-10-23 1989-04-04 Pizzolante John M Stabilized alkaline picrate reagent for jaffe creatinine determination
US5614414A (en) * 1995-03-30 1997-03-25 Streck Laboratories, Inc. Liquid lipoprotein control
US5770451A (en) * 1995-03-30 1998-06-23 Streck Laboratories, Inc. Liquid lipoprotein control
US20110250262A1 (en) * 2008-12-24 2011-10-13 Biomedcore, Inc. Method for producing liposome and method for dissolving cholesterol

Also Published As

Publication number Publication date
JPS5028896A (en) 1975-03-24
NL159193B (en) 1979-01-15
CH592309A5 (en) 1977-10-31
JPS541197B2 (en) 1979-01-22
FR2229966A1 (en) 1974-12-13
NL7405961A (en) 1974-11-18
CA1016049A (en) 1977-08-23
DE2324386B1 (en) 1974-11-07
HU169654B (en) 1977-02-28
GB1423113A (en) 1976-01-28
AT330368B (en) 1976-06-25
AR198369A1 (en) 1974-06-14
SE393191B (en) 1977-05-02
DE2324386C2 (en) 1975-07-03
FR2229966B1 (en) 1976-06-25
IT1010304B (en) 1977-01-10
DD110949A5 (en) 1975-01-12
ATA273574A (en) 1975-09-15

Similar Documents

Publication Publication Date Title
US3891573A (en) Aqueous cholesterol standard solution
Kageyama A direct colorimetric determination of uric acid in serum and urine with uricase-catalase system
Rosenthal et al. A stable iron reagent for determination of cholesterol
Hunter A new test for ergothioneine upon which is based a method for its estimation in simple solution and in blood-filtrates
GB1332258A (en) Dual response photosensitive compositions
JPH05107680A (en) Aqueous hydrazide solution for photographic element
JPS6134799B2 (en)
US3721607A (en) Reagent composition and process for the determination of glucose
US4407962A (en) Composition for the colorimetric determination of metals
Pon et al. Molecular weight and amino acid composition of five-times-crystallized phosphoglucose isomerase from rabbit skeletal muscle
De Sousa et al. Blockade of the hydrosmotic effect of vasopressin by cytochalasin B
Struck et al. Polarographic Study of the System Alloxan-Alloxantin-Dialuric Acid
US4382075A (en) Stabilized Romanowsky stain solution
US3971702A (en) Diagnostic composition for saccharide determination
Manabe et al. The Partial Molal Volumes of Normal Chain Alcohols in Water–Ethanol Mixtures at 25° C
Conklin et al. A quantitative procedure for the determination of nitrofurantoin in whole blood and plasma
Blaies et al. A simplified method for staining mast cells with astra blue
US4868139A (en) Aqueous cholesterol standard solution and process for its preparation
US4239649A (en) Cholesterol standard
GB1211302A (en) Barium sulphate reflectance standards
Johnson et al. The effect of oxygen on the determination of 17-ketosteroids with tetrazolium salts
SU416969A3 (en)
Rosenthal et al. ACID—BASE EQUILIBRIA IN CONCENTRATED SALT SOLUTIONS. I. POTENTIOMETRIC MEASUREMENTS, INDICATOR MEASUREMENTS, AND UNCHARGED BASES IN DILUTE ACID SOLUTIONS1
SUMPTER et al. The polarographic behavior of isatin
US4965210A (en) Stable reagent for determining bilirubin in serum and method of preparation